How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association …

B Pieske, C Tschöpe, RA De Boer… - European heart …, 2019 - academic.oup.com
Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF)
remains a challenge. We recommend a new stepwise diagnostic process, the 'HFA–PEFF …

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart …

Authors/Task Force Members… - European heart …, 2012 - academic.oup.com
The task of develo** ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

Empagliflozin in acute myocardial infarction: the EMMY trial

D von Lewinski, E Kolesnik, NJ Tripolt… - European heart …, 2022 - academic.oup.com
Aims Sodium–glucose co-transporter 2 inhibition reduces the risk of hospitalization for heart
failure and for death in patients with symptomatic heart failure. However, trials investigating …

[HTML][HTML] Russian heart failure society, Russian society of cardiology. Russian scientific medical society of internal medicine guidelines for heart failure: chronic (CHF) …

VY Mareev, IV Fomin, FT Ageev, YL Begrambekova… - Kardiologiia, 2018 - lib.ossn.ru
РЕКОМЕНДАЦИИ, СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ, ХРОНИЧЕСКАЯ СЕРДЕЧНАЯ
НЕДОСТАТОЧНОСТЬ, ОСТРАЯ ДЕКОМПЕНСАЦИЯ СЕРДЕЧНОЙ …

Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care

P Hildebrandt, PO Collinson, RN Doughty… - European heart …, 2010 - academic.oup.com
Aims The study evaluated the use of age-related decision limits for N-terminal pro-B-type
natriuretic peptide (NT-proBNP), for ruling out suspected systolic dysfunction in symptomatic …

Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review

RA Booth, SA Hill, A Don-Wauchope, PL Santaguida… - Heart failure …, 2014 - Springer
National and international guidelines have been published recommending the use of
natriuretic peptides as an aid to the diagnosis of heart failure (HF) in acute settings; …

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure

GC Fonarow, WF Peacock, CO Phillips… - Journal of the American …, 2007 - jacc.org
Objectives: This study was designed to determine whether admission B-type natriuretic
peptide (BNP) levels are predictive of in-hospital mortality in acute decompensated heart …

[PDF][PDF] 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

P Ponikowski, AA Voors, SD Anker… - Kardiologia Polska …, 2016 - journals.viamedica.pl
5.2. 1. Ocena funkcji skurczowej lewej komory...................................... 1052 5.2. 2. Ocena
funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …

Changes in cardiovascular biomarkers with breast cancer therapy and associations with cardiac dysfunction

BG Demissei, RA Hubbard, L Zhang… - Journal of the …, 2020 - Am Heart Assoc
Background We examined the longitudinal associations between changes in cardiovascular
biomarkers and cancer therapy–related cardiac dysfunction (CTRCD) in patients with breast …

B-type natriuretic peptide levels and mortality in patients with and without heart failure

MK York, DK Gupta, CF Reynolds… - Journal of the American …, 2018 - jacc.org
Background: Circulating B-type natriuretic peptide (BNP) concentrations strongly predict
mortality in patients with heart failure (HF). Both cardiac and extracardiac stimuli influence …